Whalegun
Home

Helen M. Thackray, Chief R&D Officer: Biocryst Pharmaceuticals BCRX Planned sale · Filed 25/11/25

Trade details

Type
Planned sale notice
Stock
Biocryst Pharmaceuticals BCRX
Person
Helen M. ThackrayChief R&D Officer
Planned sale date
25/11/25
Filed
25/11/25

More to sell after $304.2K in 3 months

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/26~25/12/25

Helen M. Thackray's recent trades

  • Helen M. Thackray

    Planned saleBiocryst Pharmaceuticals

    $307.7K

    Filed 25/11/21

  • Helen M. Thackray

    BuyBiocryst Pharmaceuticals

    $175.8K

    Filed 24/05/15

  • Helen M. Thackray

    Sell10b5-1 planBiocryst Pharmaceuticals

    $58K

    Filed 23/04/05

Helen M. Thackray, Chief Officer — plans to sell 48,229 sh of Biocryst Pharmaceuticals BCRX · $328K · around 11/25 | Whalegun